Lv51
940 积分 2022-07-04 加入
Method development and validation of unbound saccharide content (serogroup A, C, Y, W, X) in novel pentavalent meningococcal polysaccharide conjugate vaccine with two different carrier proteins
1个月前
已完结
Acid hydrolysis conditions for quantification of meningococcal X polysaccharide in a pentavalent vaccine using HPAEC-PAD/ESI-MS
1个月前
已完结
Molecular size distribution in pentavalent (A, C, Y, W, X) meningococcal polysaccharide conjugate vaccine by HPSEC-UV-MALS-RI method- a conceivable stability indicating parameter
1个月前
已完结
Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD)
6个月前
已完结
Recent progress and advances towards developing enterovirus 71 vaccines for effective protection against human hand, foot and mouth disease (HFMD)
6个月前
已完结
Vaccines: EU Regulatory Requirements
7个月前
已完结
Recent Advancement in mRNA Vaccine Development and Applications. Pharmaceutics
8个月前
已完结
How mRNA is powering a personalized vaccine revolution
8个月前
已完结
Clinical advances and ongoing trials on mRNA vaccines for cancer treatment
8个月前
已完结
CMC and QMS Regulatory Requirements and Challenges for mRNA-based Vaccines
9个月前
已关闭
皖公网安备34019202002308
